¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"resource based relative value scale"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • normal value
    Á¤»óÄ¡, Á¤»ó°ª
  • positive predictive value
    ¾ç¼º¿¹ÃøÄ¡
  • predictive value
    ¿¹ÃøÄ¡
  • reference value
    ±âÁØÄ¡, ±âÁذª
  • value
    °ª, °¡Ä¡, Ä¡
  • value system
    °¡Ä¡Ã¼°è
  • haploidentical relative
    Ȭ¹è¼öµ¿Á¾°ü°è
  • relative
    1. °ü°è- 2. »ó´ëÀû- 3. ģô
  • relative biologic effectiveness radiation
    »ó´ë»ý¹°ÇÐÀûÈ¿°ú¹æ»ç¼±
  • relative convergence
    »ó´ë´«¸ðÀ½
  • relative flatness
    »ó´ëŹÀ½
  • relative frequency
    »ó´ëºóµµ, ºñ±³ºóµµ
  • relative hearing
    »ó´ëÀûû°¨
  • relative humidity
    »ó´ë½Àµµ
  • relative immunity
    »ó´ë¸é¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • molar buffer value
    ¸ô¿ÏÃæ°¡
  • normal value
    Á¤»óÄ¡
  • positive predictive value
    ¾ç¼º¿¹ÃøÄ¡
  • predictive value
    ¿¹ÃøÄ¡
  • spatial value
    °ø°£°¡
  • symbolic value
    »ó¡°¡Ä¡
  • value system
    °¡Ä¡Ã¼°è
  • threshold value
    ¹®Åΰª, ¿ªÄ¡
  • typical value
    ´ëǥġ
  • value
    °ª, °¡Ä¡, Ä¡
  • relative acidosis
    »ó´ëÀû»êÁõ
  • relative convergence
    »ó´ë´«¸ðÀ½
  • relative afferent pupillary defect
    ºñ±³µé½Å°æµ¿°ø°á¼Õ
  • relative risk estimation
    »ó´ëÀ§ÇèµµÃßÁ¤
  • relative flatness
    »ó´ëŹÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • predictive value of control signal
    Á¦¾î<´ëÁ¶>½ÅÈ£ÀÇ ¿¹ÃøÄ¡
  • previous value check
    °ú°ÅÄ¡(ΦËÛö·)°Ë»ö(Ëþßã)
  • principal value of strain
    ¿ÖÁÖÄ¡(èàñ«öÇ).
  • recombination value
    Àç°áÇÕ°ª.
  • Cattell infant intelligence scale
    Ä«ÅÚ¿µ¾Æ Áö´É°èÃø.
  • Conners Hyperactivity Rating Scale
    ÄÚ³Ê °úȰµ¿¼º Æò°¡ ôµµ(~ΦüÀÔÑàõøÄʤô©Óø)
  • Defensive Functioning Scale
    ¹æ¾î±â´Éôµµ(ÛÁåÝÐüÒöô©Óø)
  • Depression Self-Rating Scale
    ¿ì¿ïÁõ ÀÚ±â-Æò°¡ ôµµ(éØê¦ñø í»Ðù-øÄʤ ô©Óø)
  • Fahrenheit thermometric scale
    È­¾¾¿Âµµ ±âÁØ.
  • Gaffkys scale(table)
    °¡ÇÁ۵µÇ¥<Ç¥> °´´ã¾à»ç .
  • PANSS=Positive and Negative Syndrome Scale
    ¾ç¼º À½¼º ÁõÈıº ôµµ
  • SANS, Scale for the Assessment of Negative Symptoms
    À½¼ºÁõ»óÆò°¡Ã´µµ
  • SAPS, Scale for the Assessment of Positive Symptoms
    ¾ç¼ºÁõ»óÆò°¡Ã´µµ
  • SOFAS, Social and Occupational Functioning Assessment Scale
    »çȸ-Á÷¾÷±â´ÉÆò°¡Ã´µµ
  • WAIS= Wechsler Adult Intelligence Scale
    ¿þÅ©½½·¯¼ºÀÎÁö´É°Ë»ç(~à÷ìÑò±ÒöËþÞÛ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gray scale
    ȸ»öÁ¶
  • gray scale
    ȸ»öÁ¶, ȸ»ö ½ºÄÉÀÏ
  • gray scale display
    ȸ»öÁ¶ Ç¥½Ã
  • gray scale ultrasonography
    ȸ»öÁ¶ ÃÊÀ½ÆÄ°Ë»ç
  • gray-scale
    ȸ»öÁ¶
  • harmonic scale
    È­¼º(Àû) À½°è
  • horny scale
    °¢Áúºñ´Ã
  • hydrogen scale
    ¼ö¼ÒÀü±ØÀüÀ§Ã´µµ.
  • life change scale
    »ýȰº¯È­Ã´µµ(~ô©Óø)
  • linear scale
    ±Õµî(Ë»ËÄ)´«±Ý.
  • logarithmic scale
    ·Î±×´«±Ý, ´ë¼ö´«±Ý, ·Î±×ÀÚ.
  • micaceous scale
    ¿î¸ð»óÀμ³
  • musical scale
    À½°è(ëåÍ­).
  • placoid scale
    ¼ø¸°(âäìç)
  • scala consistentiae ³ª =consistency scale
    (ÀڱðæºÎ)°æµµÃ´µµ (í­ÏàÌòÝ»Ìãöôô©Óø).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • relative substrate concentration
    »ó´ë ±âÁú³óµµ(ßÓÓßÐñòõÒØÓø)
  • relative variance
    »ó´ë °¡º¯µµ(ßÓÓßÊ¦Ü¨Óø)
  • relative viscosity
    »ó´ë Á¡µµ(ßÓÓßïÄÓø)
  • biological value
    »ý¹°°¡(ßæÚªÊ¤)
  • buffer value
    ¿ÏÃæ(èÐõú)°ª
  • caloric value
    Ä®·Î¸® °ª
  • Cot value
    Cot Ä¡(ö·)
  • C value
    C °ª
  • C value paradox
    C °ª ÆÄ¶óµ¶½º
  • dilution value of buffer
    ¿ÏÃæ¾× Èñ¼®°¡(èÐõúäûýüà·Ê¤)
  • D value
    D °ª (ÔÒ) decimal reduction time
  • ester value
    ¿¡½ºÅÍ °ª
  • F value
    F °ª
  • g value
    g °ª
  • G value
    G °ª
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • value
    °ª, °¡Ä¡
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
RVI relative value index; right ventricle infarction
RVU relative value unit
RF radial fiber; radio frequency; receptive field; regurgitant fraction; Reitland-Franklin [unit]; rela...
RR radiation reaction; radiation response; rate ratio; rational recovery [group]; recovery room; relati...
RSA rabbit serum albumin; regular spiking activity; relative specific activity; relative standard accura...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PIR Protein Identification Resource
RAWP Resource Allocation Working Party
RCRA Resource Conservation and Recovery Act
RUG Resource Utilization Group
URL uniform resource locator
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • boundary value
    °æ°èÄ¡
  • correction value
    º¸Á¤Ä¡
  • fasting value
    °øº¹Ä¡
  • mean value
    Æò±ÕÄ¡
  • molar buffer value
    ¸ô ¿ÏÃæ°¡
  • negative predictive value
    À½¼º ¿¹»óÄ¡
  • normal value
    Á¤»óÄ¡, Ç¥ÁØÄ¡, ±ÔÁ¤Ä¡
  • observed value
    °üÃøÄ¡
  • osmotic value
    »ïÅõ °ª
  • symbolic value
    »ó¡ °¡Ä¡
  • threshold value
    ¿ªÄ¡
    ½Å°æÀ̳ª ±ÙÀ° µî¿¡ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â µ¥ ÇÊ¿äÇÑ ÃÖ¼Ò ÀÚ±Ø °ª. ÃÖ¼Ò ÇÑ°è °ªÀ̶ó°íµµ ÇÑ´Ù. ÀÛ¿ë ¿øÀο¡ µû¶ó ¿ªÄ¡ÀÇ Á¾·ùµµ ¿©·¯ °¡Áö°¡ ÀÖ´Ù. ÀÚ±Ø ÀÛ¿ëÀÏ ¶§´Â ÀڱؿªÀ̶ó Çϰí, ±× Áß¿¡¼­µµ °¨°¢ Á¾·ù¿¡ µû¶ó ½Ã°¢¿ª, û°¢¿ªÀ̶ó°í ºÎ¸¥´Ù. ÀÌµé °ªÀº »ýü°¡ ÀÚ±ØÀ» ¹Þ¾Æ ÈïºÐÀ» ³ªÅ¸³»´Â ´É·Â, Áï ÈïºÐ¼ºÀÇ Ã´µµ·Î »ïÀ» ¼öµµ ÀÖ´Ù. ÀÚ±Ø È¿°ú´Â ±× °­µµ»Ó ¾Æ´Ï¶ó, ÀÚ±ØÀÇ Áö¼Ó ½Ã°£À̳ª °­µµÀÇ ½Ã°£Àû °æ°ú¿¡ µû¶ó Á¿ìµÈ´Ù. ¶Ç, ¼Ò¸®³ª ºû°ú °°ÀÌ ÀÛ¿ë ¿øÀÎÀÇ ¾çÀûÀÎ Â÷°¡ ÀÚ±Ø È¿°ú¿Í °°Àº °æ¿ì´Â ½Äº°¿ªÀ̶óµçÁö ±¸º°¿ªÀ̶ó Çϰí, ¾çÀûÀÎ Â÷¸¦ ¹®Á¦ ½ÃÇÏÁö ¾Ê´Â ÀÏ¹Ý ¿ªÄ¡¸¦ ´Ü¼ø¿ªÀ̶ó°í ÇÑ´Ù.
  • value judgement
    °¡Ä¡ ÆÇ´Ü
  • adhesive scale
    À¯Âø¼º Àμ³
  • beam scale
    ´ëÀú¿ï
  • Celsius scale
    ¼·¾¾ ´«±Ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
relative afferent pupillary defect An asymmetry of the pupillomotor input between the two eyes; tested by alternating the light from one eye to the other and comparing the direct light reactions.
(05 Mar 2000)
relative aperture <microscopy> The ratio of the focal length of a lens to the diameter of its entrance pupil. This gives a number known as the f-number, usually written f:8, f:16, etc. Thus, if the focal length is divided by the number 8, 16, etc., the result will be the diameter of the entrance pupil of the lens, or if the diaphragm of the lens is wide open it will be very nearly the diameter of the free aperture of the lens.
See: F-number.
(05 Aug 1998)
relative basal area An estimate of basal area for trees, such as produced by the Bitterlich sampling technique.
(09 Oct 1997)
relative biological effectiveness The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays.
(12 Dec 1998)
relative dehydration Water deficit relative to content of solutes contributing effective osmotic pressure; a state of increased effective osmotic pressure of body fluids.
(05 Mar 2000)
relative immunity A modified, not completely effective resistance that results when there is a sort of "fluctuating equilibrium" between the defense mechanisms of the host and the infective agent.
(05 Mar 2000)
relative incompetence Imperfect closure of a cardiac valve, in consequence of excessive dilation of the corresponding cavity of the heart.
(05 Mar 2000)
relative leukocytosis An increased proportion of one or more types of leukocytes in the circulating blood, without an actual increase in the total number of white blood cells.
(05 Mar 2000)
relative molecular mass The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
relative polycythemia A relative increase in the number of red blood cells as a result of loss of the fluid portion of the blood.
(05 Mar 2000)
relative refractory period The period between the effective refractory period and the end of the refractory period; fibres then respond only to high intensity stimuli and the impulses conduct more slowly than normally.
(05 Mar 2000)
relative risk <epidemiology> The proportion of diseased people amongst those exposed to the relevant risk factor divided by the proportion of diseased people amongst those not exposed to the risk factor. This should be used in those cohort studies where those with and without disease are followed to observe which individuals become diseased.
(05 Dec 1998)
relative scotoma A scotoma in which there is visual depression but not complete loss of light perception.
(05 Mar 2000)
relative sensitivity The sensitivity of a medical screening test as determined by comparison with the same type of test; e.g., sensitivity of a new serological test relative to sensitivity of an established serological test.
(05 Mar 2000)
relative specificity The specificity of a medical screening test as determined by comparison with the same type of test (e.g., specificity of a new serological test relative to specificity of an established serological test).
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • relative clause
    °ü°è»çÀý !
  • relative frequency
    »ó´ëµµ¼ö(ºóµµ)
  • relative humidity
    »ó´ë½Àµµ
  • relative majority
    »ó´ë ´Ù¼ö(¼±°Å¿¡¼­ °ú¹Ý¼ö ¹Ì´ÞÀÎ °æ¿ìÀÇ ¼öÀ§)
  • relative pronoun
    °ü°è ´ë¸í»ç
  • scale
    Àú¿ïÀÇ Á¢½Ã
  • Burnham scale
    °ø¸³Çб³±³¿øºÀ±Þ±âÁØÇ¥
  • HO scale
    HOÃàô(ÀÚµ¿Â÷,öµµ ¸ðÇüÀÇ Ãàô)
  • Richter scale
    ¸®È÷ÅÍ ½ºÄÉÀÏ(ÁöÁøÀÇ Áøµµ ôµµ,1-10±îÁö ÀÖÀ½)
  • beaufort scale
    º¸ÆÛÆ® dz·Â°è±Þ
  • chromatic scale
    ¹ÝÀ½°è
  • escalator scale
    ¿¡½ºÄ÷¹ÀÌÅÍ Á¶Ç׿¡ ÀÇÇÑ ÀÓ±Ý Ã¼°è
  • gapped scale
    °¸Æ® ½ºÄÉÀÏ(½ÇÁ¦ ¾²Áö ¾ÊÀº À½À» »« À½°è
  • grand scale
    ´ëÇüÀÇ;´ë±Ô¸ðÀÇ;´Ù´ëÇÑ;Á¤·ÂÀûÀÎ
  • major scale
    ÀåÀ½°è
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á